AZITHROMYCIN

AZITHROMYCIN was reported 59749 times

AZITHROMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 123 0.8786
1 VAGINAL FLATULENCE 155 0.5116
2 CONGENITAL HIATUS HERNIA 105 0.4605
3 TOTAL LUNG CAPACITY INCREASED 119 0.4375
4 HEART SOUNDS 40 0.4167
5 PULMONARY VASCULITIS 174 0.3234
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 162 0.3098
7 TOTAL LUNG CAPACITY ABNORMAL 110 0.2828
8 CAPILLARITIS 56 0.2029
9 DELIVERY 126 0.1912
10 SPIROMETRY ABNORMAL 107 0.1789
11 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 37 0.1674
12 PROLONGED EXPIRATION 43 0.1641
13 MITE ALLERGY 104 0.1588
14 MYCOBACTERIUM ABSCESSUS INFECTION 90 0.1259
15 MYCOBACTERIUM AVIUM COMPLEX INFECTION 318 0.1183
16 MYCOTIC ALLERGY 100 0.1170
17 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 106 0.1143
18 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 83 0.1132
19 DUST ALLERGY 109 0.1111
20 NEURITIS 162 0.1049
21 RHINOCEREBRAL MUCORMYCOSIS 36 0.1037
22 PULMONARY FUNCTION TEST ABNORMAL 152 0.0975
23 FEMALE GENITAL TRACT FISTULA 160 0.0936
24 ABORTION INCOMPLETE 154 0.0827
25 BRONCHIECTASIS 545 0.0808
26 CONJUNCTIVITIS ALLERGIC 115 0.0776
27 PHOTODERMATOSIS 32 0.0758
28 CHRONIC SINUSITIS 280 0.0745
29 RESPIRATORY SYMPTOM 210 0.0738
30 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 143 0.0701
31 BREATH SOUNDS ABNORMAL 333 0.0675
32 RADICULOPATHY 170 0.0644
33 BRONCHIAL WALL THICKENING 45 0.0626
34 RHINITIS ALLERGIC 275 0.0617
35 PULMONARY CAVITATION 53 0.0609
36 FORCED EXPIRATORY VOLUME DECREASED 169 0.0596
37 PROCTITIS 156 0.0556
38 MALIGNANT MELANOMA IN SITU 68 0.0549
39 BONE DEMINERALISATION 58 0.0548
40 MYCOBACTERIAL INFECTION 93 0.0539
41 TOTAL LUNG CAPACITY DECREASED 86 0.0538
42 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 57 0.0537
43 FULL BLOOD COUNT ABNORMAL 568 0.0537
44 OBSTRUCTIVE AIRWAYS DISORDER 589 0.0529
45 ATYPICAL MYCOBACTERIAL INFECTION 74 0.0523
46 BACTERIAL DISEASE CARRIER 38 0.0521
47 BILIARY DYSKINESIA 88 0.0518
48 NASAL POLYPS 255 0.0517
49 LUNG TRANSPLANT REJECTION 34 0.0515
50 CYSTIC FIBROSIS 277 0.0500
51 OTOTOXICITY 92 0.0497
52 LUNG OPACITY 123 0.0466
53 HYPERPARATHYROIDISM SECONDARY 110 0.0439
54 IMMUNE RECONSTITUTION SYNDROME 56 0.0434
55 CHEST X-RAY ABNORMAL 130 0.0424
56 MYCOPLASMA INFECTION 32 0.0410
57 MACULAR DEGENERATION 485 0.0406
58 NEPHROGENIC ANAEMIA 187 0.0403
59 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 36 0.0403
60 REBOUND ACID HYPERSECRETION 122 0.0403
61 BRONCHIAL HYPERREACTIVITY 48 0.0399
62 HILAR LYMPHADENOPATHY 34 0.0386
63 STENOTROPHOMONAS INFECTION 52 0.0383
64 PULMONARY ALVEOLAR HAEMORRHAGE 205 0.0365
65 CHOLECYSTITIS CHRONIC 241 0.0360
66 NORMOCHROMIC NORMOCYTIC ANAEMIA 108 0.0359
67 SPUTUM DISCOLOURED 340 0.0358
68 RALES 206 0.0354
69 BRONCHIAL SECRETION RETENTION 45 0.0353
70 PNEUMONIA PSEUDOMONAL 53 0.0345
71 SPUTUM RETENTION 33 0.0333
72 EAR PRURITUS 116 0.0330
73 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 175 0.0321
74 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 544 0.0320
75 JAUNDICE CHOLESTATIC 108 0.0305
76 NEUROLOGICAL SYMPTOM 173 0.0302
77 RHONCHI 41 0.0297
78 INFUSION SITE DISCHARGE 52 0.0296
79 SPUTUM INCREASED 62 0.0286
80 PLEURITIC PAIN 79 0.0286
81 PNEUMATOSIS INTESTINALIS 81 0.0284
82 VANISHING BILE DUCT SYNDROME 31 0.0278
83 SARCOIDOSIS 131 0.0275
84 UPPER-AIRWAY COUGH SYNDROME 221 0.0268
85 VASCULITIS 309 0.0265
86 TACHYARRHYTHMIA 64 0.0256
87 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 68 0.0255
88 DEAFNESS NEUROSENSORY 83 0.0252
89 GALLBLADDER INJURY 48 0.0246
90 HYPOMANIA 90 0.0244
91 BENIGN PROSTATIC HYPERPLASIA 126 0.0244
92 DEAFNESS BILATERAL 41 0.0241
93 MUCORMYCOSIS 62 0.0238
94 BLOOD LACTIC ACID INCREASED 124 0.0235
95 PREMATURE DELIVERY 372 0.0233
96 WHEEZING 1315 0.0222
97 END STAGE RENAL DISEASE 404 0.0221
98 PULMONARY FUNCTION TEST DECREASED 96 0.0219
99 HAEMOPTYSIS 600 0.0215
100 ORAL CANDIDIASIS 277 0.0210
101 HYPERCAPNIA 63 0.0209
102 ARTERIOSCLEROSIS CORONARY ARTERY 137 0.0207
103 ISCHAEMIC CARDIOMYOPATHY 63 0.0205
104 CARDIAC MURMUR 176 0.0203
105 HALLUCINATIONS, MIXED 83 0.0197
106 PSEUDOMONAS INFECTION 169 0.0197
107 PRODUCTIVE COUGH 937 0.0196
108 INFUSION SITE BRUISING 42 0.0194
109 SINUS PAIN 45 0.0193
110 PULMONARY INFARCTION 45 0.0190
111 INCREASED BRONCHIAL SECRETION 48 0.0187
112 PNEUMOMEDIASTINUM 33 0.0182
113 BLOOD PRESSURE SYSTOLIC ABNORMAL 45 0.0182
114 CHRONIC KIDNEY DISEASE 1373 0.0181
115 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 90 0.0180
116 ECONOMIC PROBLEM 270 0.0178
117 MULTIPLE-DRUG RESISTANCE 55 0.0177
118 PATHOGEN RESISTANCE 160 0.0175
119 PULMONARY FIBROSIS 334 0.0174
120 ACTINIC KERATOSIS 45 0.0173
121 RHINOVIRUS INFECTION 67 0.0172
122 ANHEDONIA 446 0.0170
123 VAGINAL DISCHARGE 169 0.0167
124 PNEUMONIA BACTERIAL 153 0.0167
125 IMPAIRED QUALITY OF LIFE 236 0.0164
126 ASPERGILLUS INFECTION 106 0.0161
127 WOUND COMPLICATION 55 0.0160
128 INFUSION SITE PRURITUS 50 0.0158
129 BRONCHOPULMONARY ASPERGILLOSIS 122 0.0157
130 PSEUDOMEMBRANOUS COLITIS 35 0.0157
131 EOSINOPHILIA 273 0.0156
132 METHAEMOGLOBINAEMIA 36 0.0155
133 BLOOD PRESSURE DIASTOLIC ABNORMAL 39 0.0153
134 ASTHMA 1726 0.0153
135 PARAESTHESIA ORAL 220 0.0152
136 DRUG RESISTANCE 386 0.0150
137 LUNG CONSOLIDATION 42 0.0150
138 ELECTROCARDIOGRAM QT PROLONGED 535 0.0149
139 HYPOXIA 520 0.0148
140 ARTERIOSCLEROSIS 138 0.0146
141 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 755 0.0145
142 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 695 0.0145
143 BLOOD IMMUNOGLOBULIN E INCREASED 35 0.0144
144 INFUSION SITE HAEMORRHAGE 47 0.0143
145 LIP OEDEMA 60 0.0142
146 LOW BIRTH WEIGHT BABY 112 0.0141
147 LUNG NEOPLASM 60 0.0140
148 HYPERCHOLESTEROLAEMIA 135 0.0140
149 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 762 0.0139
150 FLANK PAIN 130 0.0139
151 THROMBOPHLEBITIS SUPERFICIAL 42 0.0138
152 LONG QT SYNDROME 33 0.0138
153 PNEUMONIA FUNGAL 54 0.0137
154 PREMATURE BABY 404 0.0134
155 LUNG DISORDER 651 0.0133
156 PNEUMONIA VIRAL 42 0.0132
157 PULMONARY MASS 196 0.0131
158 TORSADE DE POINTES 103 0.0131
159 OESOPHAGEAL CANDIDIASIS 52 0.0130
160 ACUTE RESPIRATORY FAILURE 249 0.0129
161 HYPERTRANSAMINASAEMIA 90 0.0129
162 INFUSION SITE SWELLING 81 0.0129
163 DEPRESSIVE SYMPTOM 45 0.0128
164 MULTIPLE ALLERGIES 100 0.0127
165 PARANASAL SINUS DISCOMFORT 48 0.0127
166 DYSPNOEA EXERTIONAL 477 0.0127
167 SUSPECTED OFF LABEL USE 57 0.0126
168 DEVICE INFUSION ISSUE 31 0.0125
169 LUNG INFILTRATION 110 0.0124
170 MASTICATION DISORDER 38 0.0124
171 BILIARY COLIC 36 0.0124
172 COVID-19 PNEUMONIA 146 0.0124
173 THERAPEUTIC AGENT TOXICITY 41 0.0123
174 RESPIRATION ABNORMAL 84 0.0122
175 TOXIC EPIDERMAL NECROLYSIS 185 0.0122
176 HEPATIC CYTOLYSIS 155 0.0121
177 ORGANISING PNEUMONIA 60 0.0121
178 EXERCISE TOLERANCE DECREASED 69 0.0120
179 ABDOMINAL MASS 32 0.0119
180 RESPIRATORY TRACT INFECTION 311 0.0119
181 ORTHOPNOEA 38 0.0119
182 THERMAL BURN 84 0.0118
183 UPPER RESPIRATORY TRACT INFECTION 538 0.0116
184 EOSINOPHIL COUNT INCREASED 97 0.0116
185 INFUSION SITE ERYTHEMA 98 0.0116
186 GASTROOESOPHAGEAL REFLUX DISEASE 927 0.0115
187 ASTHMATIC CRISIS 42 0.0115
188 SECRETION DISCHARGE 144 0.0115
189 OBESITY 182 0.0114
190 EMPHYSEMA 115 0.0114
191 OSTEOPENIA 173 0.0114
192 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 807 0.0113
193 ACUTE RESPIRATORY DISTRESS SYNDROME 200 0.0113
194 MIXED LIVER INJURY 34 0.0113
195 RENAL TUBULAR NECROSIS 109 0.0111
196 ODYNOPHAGIA 65 0.0109
197 ATELECTASIS 105 0.0109
198 ASPIRATION 118 0.0108
199 PULMONARY PAIN 31 0.0106
200 NODULE 137 0.0105
201 LUNG TRANSPLANT 37 0.0104
202 SNORING 39 0.0103
203 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 80 0.0103
204 TUBULOINTERSTITIAL NEPHRITIS 193 0.0103
205 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 34 0.0103
206 APPETITE DISORDER 68 0.0102
207 CHRONIC GRAFT VERSUS HOST DISEASE 37 0.0102
208 BRONCHIOLITIS 36 0.0102
209 PLATELET COUNT INCREASED 132 0.0101
210 MULTIPLE INJURIES 63 0.0100
211 CLOSTRIDIUM DIFFICILE COLITIS 106 0.0100
212 MICTURITION URGENCY 112 0.0098
213 GALLBLADDER DISORDER 174 0.0097
214 CHOLELITHIASIS 319 0.0097
215 DEAFNESS 254 0.0097
216 RESPIRATORY SYNCYTIAL VIRUS INFECTION 84 0.0096
217 SEASONAL ALLERGY 136 0.0096
218 BLOOD CALCIUM INCREASED 83 0.0095
219 SINUS CONGESTION 127 0.0094
220 INFUSION SITE PAIN 121 0.0094
221 STEVENS-JOHNSON SYNDROME 208 0.0093
222 STILLBIRTH 45 0.0093
223 CUTANEOUS VASCULITIS 34 0.0093
224 ENTEROCOCCAL INFECTION 45 0.0093
225 HYPOGAMMAGLOBULINAEMIA 61 0.0093
226 LOWER RESPIRATORY TRACT INFECTION 422 0.0093
227 GRANULOMA 32 0.0092
228 TACHYPNOEA 125 0.0092
229 DRUG-INDUCED LIVER INJURY 288 0.0092
230 HYPERVENTILATION 53 0.0091
231 CACHEXIA 47 0.0091
232 PULMONARY CONGESTION 120 0.0091
233 INJURY 638 0.0091
234 ACUTE KIDNEY INJURY 1388 0.0091
235 HEPATIC NECROSIS 34 0.0090
236 PNEUMOTHORAX 143 0.0090
237 ABDOMINAL TENDERNESS 43 0.0087
238 SQUAMOUS CELL CARCINOMA OF SKIN 52 0.0086
239 SWOLLEN TONGUE 268 0.0086
240 RHINITIS 69 0.0085
241 KLEBSIELLA INFECTION 43 0.0085
242 HEPATOTOXICITY 189 0.0085
243 SPINAL CORD COMPRESSION 33 0.0085
244 CHOLECYSTITIS ACUTE 48 0.0085
245 LEUKOCYTOSIS 152 0.0084
246 DYSPHONIA 491 0.0084
247 SNEEZING 185 0.0082
248 BRONCHITIS 608 0.0082
249 RENAL CYST 65 0.0082
250 LEFT VENTRICULAR HYPERTROPHY 35 0.0082
251 PNEUMOCYSTIS JIROVECII PNEUMONIA 82 0.0082
252 RESPIRATORY FAILURE 594 0.0081
253 COUGH 2284 0.0081
254 PHARYNGITIS 101 0.0081
255 RESPIRATORY TRACT CONGESTION 129 0.0081
256 SPINAL OSTEOARTHRITIS 71 0.0081
257 FREQUENT BOWEL MOVEMENTS 218 0.0081
258 TRICUSPID VALVE INCOMPETENCE 64 0.0080
259 ECCHYMOSIS 55 0.0080
260 SENSITIVITY TO WEATHER CHANGE 42 0.0080
261 HEPATITIS CHOLESTATIC 48 0.0080
262 OXYGEN SATURATION DECREASED 446 0.0079
263 CYTOMEGALOVIRUS INFECTION REACTIVATION 35 0.0079
264 SCHIZOPHRENIA 96 0.0079
265 SINUS DISORDER 155 0.0078
266 RESPIRATORY DISTRESS 216 0.0078
267 MATERNAL EXPOSURE DURING PREGNANCY 697 0.0078
268 INSURANCE ISSUE 119 0.0078
269 MULTIPLE ORGAN DYSFUNCTION SYNDROME 216 0.0076
270 PROCEDURAL PAIN 210 0.0076
271 HIATUS HERNIA 98 0.0076
272 NASAL CONGESTION 444 0.0075
273 TONGUE DISCOLOURATION 33 0.0075
274 BLOOD TEST ABNORMAL 106 0.0075
275 FOETAL DEATH 39 0.0075
276 INCORRECT DRUG ADMINISTRATION RATE 32 0.0075
277 ABSCESS LIMB 32 0.0075
278 CANDIDIASIS 30 0.0075
279 CHOLECYSTITIS 89 0.0075
280 BACTERIAL INFECTION 139 0.0074
281 HYPERBILIRUBINAEMIA 77 0.0074
282 MITRAL VALVE INCOMPETENCE 84 0.0074
283 ISCHAEMIA 34 0.0074
284 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 190 0.0074
285 RASH MACULO-PAPULAR 164 0.0074
286 HYPERLIPIDAEMIA 88 0.0074
287 PULMONARY TOXICITY 52 0.0073
288 NASAL DRYNESS 46 0.0073
289 PULMONARY EMBOLISM 694 0.0073
290 HYPERVOLAEMIA 36 0.0073
291 RENAL FAILURE CHRONIC 56 0.0073
292 PNEUMONIA 2354 0.0073
293 CHEST DISCOMFORT 744 0.0073
294 DRUG INTOLERANCE 701 0.0072
295 OSTEOPOROSIS 298 0.0072
296 INTERVERTEBRAL DISC DEGENERATION 67 0.0072
297 HYPOTHYROIDISM 231 0.0072
298 QUALITY OF LIFE DECREASED 97 0.0072
299 RESPIRATORY RATE INCREASED 64 0.0072
300 VENTRICULAR TACHYCARDIA 119 0.0072
301 TRANSAMINASES INCREASED 160 0.0072
302 STREPTOCOCCAL INFECTION 40 0.0072
303 RESPIRATORY DISORDER 215 0.0072
304 TINNITUS 330 0.0072
305 MENINGITIS ASEPTIC 32 0.0071
306 RENAL FAILURE 943 0.0071
307 HYPERKERATOSIS 39 0.0071
308 ONYCHOMYCOSIS 31 0.0071
309 CANDIDA INFECTION 119 0.0070
310 APHONIA 97 0.0069
311 RENAL INJURY 205 0.0069
312 BRONCHOSPASM 98 0.0069
313 TRANSPLANT REJECTION 55 0.0069
314 BLOOD BILIRUBIN INCREASED 184 0.0068
315 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 51 0.0068
316 IMMUNE THROMBOCYTOPENIA 31 0.0068
317 DRUG INTERACTION 1074 0.0068
318 DECREASED ACTIVITY 73 0.0068
319 RHINORRHOEA 436 0.0067
320 STAPHYLOCOCCAL INFECTION 222 0.0067
321 SINUSITIS 689 0.0067
322 DEAFNESS UNILATERAL 37 0.0067
323 SKIN LACERATION 73 0.0067
324 MALNUTRITION 75 0.0067
325 DYSLIPIDAEMIA 34 0.0067
326 CARDIOMEGALY 82 0.0067
327 CHOLESTASIS 128 0.0067
328 DEEP VEIN THROMBOSIS 432 0.0066
329 CARDIOMYOPATHY 98 0.0066
330 JOINT INJURY 141 0.0066
331 NEUTROPENIC SEPSIS 47 0.0066
332 VENTRICULAR FIBRILLATION 73 0.0066
333 HAEMODYNAMIC INSTABILITY 50 0.0066
334 ORAL DISORDER 48 0.0065
335 HYPERTRIGLYCERIDAEMIA 38 0.0065
336 INTERNATIONAL NORMALISED RATIO INCREASED 185 0.0065
337 HEPATITIS ACUTE 42 0.0065
338 HERPES SIMPLEX 42 0.0065
339 HEPATOMEGALY 63 0.0064
340 BACTERAEMIA 76 0.0064
341 LYMPHOEDEMA 44 0.0064
342 COLITIS 241 0.0064
343 IMMUNOSUPPRESSION 56 0.0063
344 DERMATITIS CONTACT 72 0.0063
345 HAEMOLYTIC ANAEMIA 56 0.0062
346 INCREASED UPPER AIRWAY SECRETION 32 0.0062
347 BLOOD POTASSIUM DECREASED 185 0.0061
348 PULMONARY HAEMORRHAGE 48 0.0061
349 TENDON DISORDER 40 0.0061
350 GINGIVITIS 33 0.0061
351 ACUTE HEPATIC FAILURE 83 0.0061
352 VITAMIN D DEFICIENCY 59 0.0060
353 DYSPNOEA 3410 0.0060
354 ANGIOEDEMA 265 0.0060
355 ELECTROCARDIOGRAM ABNORMAL 47 0.0060
356 PNEUMONITIS 163 0.0060
357 GRAFT VERSUS HOST DISEASE 43 0.0060
358 CONDITION AGGRAVATED 1817 0.0060
359 EAR INFECTION 159 0.0060
360 POST-TRAUMATIC STRESS DISORDER 40 0.0060
361 EMOTIONAL DISTRESS 720 0.0059
362 SWELLING FACE 386 0.0059
363 HAEMATOCRIT DECREASED 117 0.0059
364 HYDROCEPHALUS 32 0.0059
365 VIRAL INFECTION 195 0.0059
366 SINUS TACHYCARDIA 83 0.0058
367 DUODENAL ULCER 41 0.0058
368 SINUS BRADYCARDIA 56 0.0058
369 MIDDLE INSOMNIA 108 0.0058
370 WRIST FRACTURE 69 0.0058
371 EAR DISCOMFORT 59 0.0057
372 BLOOD PRESSURE SYSTOLIC INCREASED 112 0.0057
373 ANOSMIA 83 0.0057
374 MULTI-ORGAN FAILURE 99 0.0057
375 PLEURISY 34 0.0057
376 CORONARY ARTERY DISEASE 173 0.0057
377 EAR PAIN 111 0.0057
378 PAPULE 40 0.0057
379 TENDERNESS 59 0.0057
380 RECTAL HAEMORRHAGE 243 0.0057
381 PULMONARY HYPERTENSION 117 0.0056
382 DENTAL CARIES 62 0.0056
383 INFLUENZA 625 0.0056
384 LACRIMATION INCREASED 169 0.0056
385 BLOOD CREATININE INCREASED 362 0.0055
386 SUPRAVENTRICULAR TACHYCARDIA 53 0.0055
387 FOETAL EXPOSURE DURING PREGNANCY 448 0.0055
388 PLEURAL EFFUSION 335 0.0055
389 STRESS CARDIOMYOPATHY 32 0.0055
390 ACIDOSIS 42 0.0055
391 POSTOPERATIVE WOUND INFECTION 37 0.0055
392 RENAL FAILURE ACUTE 232 0.0055
393 INFUSION SITE EXTRAVASATION 34 0.0055
394 INFUSION RELATED REACTION 361 0.0054
395 SLEEP APNOEA SYNDROME 103 0.0054
396 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
397 PRODUCT USE IN UNAPPROVED INDICATION 1329 0.0054
398 PHARYNGITIS STREPTOCOCCAL 58 0.0054
399 ADRENAL INSUFFICIENCY 65 0.0054
400 IMPAIRED GASTRIC EMPTYING 73 0.0053
401 CYANOSIS 84 0.0053
402 ANXIETY 1515 0.0053
403 APHTHOUS ULCER 41 0.0053
404 BLOOD PRESSURE DIASTOLIC DECREASED 39 0.0053
405 HEPATIC STEATOSIS 98 0.0053
406 RIB FRACTURE 108 0.0052
407 GASTRITIS 138 0.0052
408 COVID-19 919 0.0052
409 HAEMATOCHEZIA 289 0.0052
410 PRODUCT ADMINISTRATION INTERRUPTED 41 0.0052
411 AGRANULOCYTOSIS 97 0.0052
412 MYOPATHY 45 0.0052
413 REFUSAL OF TREATMENT BY PATIENT 34 0.0052
414 TOOTH ABSCESS 53 0.0052
415 COLITIS ISCHAEMIC 35 0.0052
416 TRANSIENT ISCHAEMIC ATTACK 175 0.0052
417 BODY TEMPERATURE DECREASED 51 0.0052
418 HAEMOLYSIS 40 0.0052
419 OROPHARYNGEAL PAIN 479 0.0052
420 HEARING IMPAIRED 31 0.0052
421 ATRIAL SEPTAL DEFECT 43 0.0051
422 INFECTION 741 0.0051
423 IMMUNODEFICIENCY 76 0.0051
424 BODY TEMPERATURE INCREASED 104 0.0051
425 THERAPY NON-RESPONDER 229 0.0051
426 SKIN MASS 34 0.0051
427 EYE PRURITUS 171 0.0051
428 ILLNESS 524 0.0051
429 INTENTIONAL DOSE OMISSION 145 0.0051
430 MENTAL STATUS CHANGES 141 0.0051
431 BRAIN OEDEMA 64 0.0051
432 THERAPY INTERRUPTED 362 0.0051
433 DRUG ERUPTION 89 0.0050
434 DYSPEPSIA 494 0.0050
435 CONJUNCTIVITIS 92 0.0050
436 SKIN LESION 136 0.0050
437 OFF LABEL USE 4335 0.0049
438 RASH PUSTULAR 36 0.0049
439 OESOPHAGITIS 54 0.0049
440 LIVER FUNCTION TEST INCREASED 106 0.0049
441 ERYTHEMA MULTIFORME 46 0.0049
442 POOR VENOUS ACCESS 51 0.0049
443 CHOLECYSTECTOMY 56 0.0049
444 COLITIS ULCERATIVE 218 0.0049
445 RENAL IMPAIRMENT 409 0.0049
446 MUSCULOSKELETAL CHEST PAIN 75 0.0048
447 OPTIC NEURITIS 44 0.0048
448 OEDEMA PERIPHERAL 588 0.0048
449 ELECTROLYTE IMBALANCE 56 0.0048
450 EXOSTOSIS 44 0.0048
451 HAND FRACTURE 34 0.0048
452 ABDOMINAL PAIN 1115 0.0048
453 DIVERTICULUM 34 0.0048
454 PYREXIA 1649 0.0048
455 AUTOIMMUNE HEPATITIS 33 0.0047
456 PRODUCT DISTRIBUTION ISSUE 44 0.0047
457 JAUNDICE 127 0.0047
458 BLOOD ALKALINE PHOSPHATASE INCREASED 117 0.0047
459 COAGULOPATHY 78 0.0047
460 PAROSMIA 35 0.0046
461 PANCYTOPENIA 259 0.0046
462 RHABDOMYOLYSIS 193 0.0046
463 PRODUCT DOSE OMISSION IN ERROR 131 0.0046
464 FUNGAL INFECTION 154 0.0046
465 BONE DISORDER 84 0.0046
466 DISEASE RECURRENCE 219 0.0046
467 GASTROENTERITIS VIRAL 83 0.0046
468 EXTRASYSTOLES 32 0.0046
469 MYASTHENIA GRAVIS 37 0.0046
470 LYMPHADENOPATHY 162 0.0046
471 SEPTIC SHOCK 196 0.0045
472 THROAT IRRITATION 202 0.0045
473 ANAEMIA 858 0.0045
474 FEAR 121 0.0045
475 DEFORMITY 42 0.0045
476 AGEUSIA 112 0.0045
477 LIVER INJURY 110 0.0045
478 SLEEP DISORDER 316 0.0045
479 HEPATITIS 114 0.0045
480 PREGNANCY 89 0.0044
481 BONE DENSITY DECREASED 139 0.0044
482 NASAL DISCOMFORT 35 0.0044
483 DRUG LEVEL INCREASED 73 0.0044
484 WEIGHT DECREASED 1231 0.0044
485 PSYCHOTIC DISORDER 130 0.0044
486 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
487 NEPHROPATHY 41 0.0044
488 VENTRICULAR EXTRASYSTOLES 45 0.0043
489 TENDONITIS 67 0.0043
490 HALLUCINATION, VISUAL 91 0.0043
491 CHEST PAIN 796 0.0043
492 GENERAL PHYSICAL HEALTH DETERIORATION 496 0.0043
493 HALLUCINATION, AUDITORY 68 0.0043
494 FOOD ALLERGY 33 0.0043
495 DISSEMINATED INTRAVASCULAR COAGULATION 60 0.0043
496 CHROMATURIA 96 0.0042
497 ORAL HERPES 83 0.0042
498 ATRIAL FIBRILLATION 413 0.0042
499 SPINAL COMPRESSION FRACTURE 35 0.0042
500 OSTEOARTHRITIS 179 0.0042
501 PERICARDIAL EFFUSION 97 0.0042
502 GASTROENTERITIS 61 0.0042
503 HEPATIC FAILURE 126 0.0042
504 BLOOD ALBUMIN DECREASED 33 0.0042
505 FACIAL PAIN 37 0.0041
506 OSTEOMYELITIS 75 0.0041
507 MULTIPLE FRACTURES 68 0.0041
508 NIGHT SWEATS 133 0.0041
509 FACE OEDEMA 69 0.0041
510 ENCEPHALOPATHY 100 0.0041
511 JOINT DISLOCATION 43 0.0041
512 RED BLOOD CELL SEDIMENTATION RATE INCREASED 45 0.0041
513 EXPOSURE DURING PREGNANCY 252 0.0041
514 CARDIAC ARREST 334 0.0040
515 LIGAMENT SPRAIN 40 0.0040
516 PULMONARY OEDEMA 181 0.0040
517 GASTROINTESTINAL DISORDER 362 0.0040
518 LUNG NEOPLASM MALIGNANT 166 0.0040
519 METABOLIC ACIDOSIS 129 0.0040
520 DRY THROAT 41 0.0040
521 DEVICE RELATED INFECTION 62 0.0040
522 SEPSIS 449 0.0040
523 BRAIN FOG 63 0.0040
524 MYOSITIS 36 0.0040
525 ATRIAL FLUTTER 32 0.0040
526 IRON DEFICIENCY ANAEMIA 37 0.0040
527 PHOTOSENSITIVITY REACTION 66 0.0040
528 HEPATIC ENZYME INCREASED 272 0.0040
529 HYPOALBUMINAEMIA 31 0.0040
530 HEART RATE INCREASED 395 0.0040
531 OROPHARYNGEAL DISCOMFORT 36 0.0040
532 HYPERSENSITIVITY 738 0.0040
533 SCAR 68 0.0040
534 RASH ERYTHEMATOUS 189 0.0039
535 TREATMENT NONCOMPLIANCE 216 0.0039
536 TACHYCARDIA 348 0.0039
537 CLOSTRIDIUM DIFFICILE INFECTION 85 0.0039
538 ROTATOR CUFF SYNDROME 50 0.0039
539 ANAL INCONTINENCE 35 0.0039
540 ABDOMINAL PAIN LOWER 97 0.0038
541 ANURIA 33 0.0038
542 BLOOD PRESSURE FLUCTUATION 92 0.0038
543 NEPHROPATHY TOXIC 43 0.0038
544 WOUND 107 0.0038
545 SHOCK 88 0.0038
546 PANCREATITIS ACUTE 86 0.0038
547 GASTROINTESTINAL PAIN 42 0.0038
548 MUSCLE STRAIN 33 0.0038
549 NASOPHARYNGITIS 703 0.0038
550 ORAL DISCOMFORT 53 0.0038
551 PAIN 2341 0.0038
552 TREATMENT FAILURE 315 0.0038
553 URTICARIA 636 0.0038
554 PALLOR 103 0.0038
555 THROMBOSIS 304 0.0038
556 BLOOD SODIUM DECREASED 71 0.0038
557 CYTOPENIA 46 0.0038
558 CELLULITIS 189 0.0037
559 MOUTH ULCERATION 79 0.0037
560 HEART RATE DECREASED 130 0.0037
561 EYELID OEDEMA 43 0.0037
562 CARDIOGENIC SHOCK 53 0.0037
563 ALANINE AMINOTRANSFERASE INCREASED 226 0.0037
564 LYMPHOPENIA 52 0.0037
565 HEART RATE IRREGULAR 83 0.0037
566 CYTOMEGALOVIRUS INFECTION 61 0.0037
567 COELIAC DISEASE 36 0.0037
568 UPPER LIMB FRACTURE 73 0.0037
569 SKIN INFECTION 41 0.0037
570 ASPARTATE AMINOTRANSFERASE INCREASED 194 0.0036
571 MYOCLONUS 43 0.0036
572 THROMBOCYTOPENIA 403 0.0036
573 ANAPHYLACTIC REACTION 198 0.0036
574 DERMATITIS ALLERGIC 45 0.0036
575 OEDEMA 193 0.0036
576 LACTIC ACIDOSIS 115 0.0035
577 BURSITIS 43 0.0035
578 PALPITATIONS 414 0.0035
579 ABDOMINAL PAIN UPPER 726 0.0035
580 BLOOD UREA INCREASED 59 0.0035
581 HYPERKALAEMIA 123 0.0035
582 PURPURA 31 0.0035
583 CONSTIPATION 763 0.0035
584 BIPOLAR DISORDER 38 0.0035
585 MENTAL DISORDER 152 0.0035
586 PRODUCT PRESCRIBING ISSUE 76 0.0035
587 RETCHING 74 0.0035
588 HEPATOCELLULAR INJURY 49 0.0035
589 HAEMATURIA 118 0.0034
590 FOOT FRACTURE 65 0.0034
591 HYPOKALAEMIA 158 0.0034
592 NEPHROLITHIASIS 157 0.0034
593 SPLENOMEGALY 40 0.0034
594 TOOTH INFECTION 45 0.0034
595 EMOTIONAL DISORDER 105 0.0034
596 LIVER FUNCTION TEST ABNORMAL 99 0.0034
597 GOUT 61 0.0034
598 GENERALISED OEDEMA 42 0.0034
599 HAEMORRHAGE 354 0.0034
600 PHARYNGEAL SWELLING 33 0.0034
601 BLOOD IRON DECREASED 40 0.0034
602 HYPERTENSION 714 0.0034
603 MUSCULOSKELETAL DISCOMFORT 58 0.0034
604 ANKLE FRACTURE 52 0.0034
605 LEUKOPENIA 168 0.0034
606 PETECHIAE 35 0.0034
607 LUNG INFECTION 52 0.0033
608 ACTIVITIES OF DAILY LIVING IMPAIRED 66 0.0033
609 ANGINA PECTORIS 95 0.0033
610 HYPOPHAGIA 84 0.0033
611 DELIRIUM 114 0.0033
612 ULCER 52 0.0033
613 IRRITABLE BOWEL SYNDROME 70 0.0033
614 VOMITING 1528 0.0032
615 PRODUCT DOSE OMISSION ISSUE 954 0.0032
616 FOLLICULITIS 34 0.0032
617 ERYTHEMA 665 0.0032
618 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
619 EJECTION FRACTION DECREASED 50 0.0032
620 RASH PRURITIC 174 0.0032
621 NECK PAIN 179 0.0032
622 DEPRESSION 728 0.0032
623 CARDIAC FAILURE CONGESTIVE 256 0.0032
624 DISCOMFORT 194 0.0032
625 TOOTH FRACTURE 35 0.0032
626 HYPOMAGNESAEMIA 44 0.0032
627 DRUG INEFFECTIVE 4162 0.0032
628 DISEASE PROGRESSION 373 0.0031
629 DYSURIA 116 0.0031
630 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
631 BRADYCARDIA 167 0.0031
632 HOSPICE CARE 31 0.0031
633 SCIATICA 50 0.0031
634 TOOTH LOSS 65 0.0031
635 HAEMORRHOIDS 61 0.0031
636 PRESYNCOPE 76 0.0031
637 DEPRESSED MOOD 165 0.0031
638 PHARYNGEAL OEDEMA 48 0.0031
639 NAUSEA 2465 0.0031
640 KIDNEY INFECTION 61 0.0031
641 DIARRHOEA 2003 0.0031
642 ORTHOSTATIC HYPOTENSION 54 0.0031
643 LIMB INJURY 84 0.0031
644 HYPONATRAEMIA 174 0.0031
645 TOXIC SKIN ERUPTION 31 0.0031
646 HYPERCALCAEMIA 38 0.0031
647 MASS 43 0.0031
648 HYPERGLYCAEMIA 112 0.0031
649 PAIN IN JAW 87 0.0031
650 CYSTITIS 97 0.0030
651 DYSPHAGIA 289 0.0030
652 TOOTHACHE 55 0.0030
653 URINARY TRACT INFECTION 517 0.0030
654 BLOOD LACTATE DEHYDROGENASE INCREASED 48 0.0030
655 OCULAR DISCOMFORT 34 0.0030
656 RENAL DISORDER 141 0.0030
657 HYPOACUSIS 130 0.0030
658 PANIC ATTACK 110 0.0030
659 BLOOD POTASSIUM INCREASED 49 0.0030
660 GLOMERULAR FILTRATION RATE DECREASED 37 0.0030
661 HYPOTENSION 603 0.0030
662 CHILLS 352 0.0030
663 RASH 1308 0.0030
664 CYTOKINE RELEASE SYNDROME 60 0.0030
665 CATARACT 178 0.0030
666 TREMOR 495 0.0030
667 SKIN DISCOLOURATION 137 0.0030
668 HEADACHE 1862 0.0030
669 HIP FRACTURE 95 0.0030
670 CARPAL TUNNEL SYNDROME 41 0.0029
671 INFLAMMATION 151 0.0029
672 MALAISE 1283 0.0029
673 EYE INFECTION 33 0.0029
674 RESTLESS LEGS SYNDROME 53 0.0029
675 C-REACTIVE PROTEIN INCREASED 106 0.0029
676 ASTHENIA 1094 0.0029
677 ORAL PAIN 65 0.0029
678 FEBRILE NEUTROPENIA 191 0.0029
679 SARS-COV-2 TEST POSITIVE 38 0.0029
680 NEUROPATHY PERIPHERAL 273 0.0029
681 BLOOD PRESSURE ABNORMAL 57 0.0029
682 ATAXIA 34 0.0029
683 FAECES DISCOLOURED 62 0.0029
684 THROAT TIGHTNESS 77 0.0028
685 PERIPHERAL COLDNESS 39 0.0028
686 FIBROMYALGIA 69 0.0028
687 COLD SWEAT 50 0.0028
688 ARTHRITIS 223 0.0028
689 CARDIO-RESPIRATORY ARREST 118 0.0028
690 THERAPY PARTIAL RESPONDER 44 0.0028
691 BACK PAIN 655 0.0028
692 HAEMOGLOBIN DECREASED 289 0.0028
693 DEHYDRATION 375 0.0028
694 ANAPHYLACTIC SHOCK 72 0.0028
695 GASTRIC ULCER 53 0.0028
696 DECREASED APPETITE 646 0.0028
697 HAEMATOMA 72 0.0028
698 HEMIPARESIS 47 0.0028
699 VERTIGO 169 0.0028
700 SYNCOPE 277 0.0028
701 HOSPITALISATION 424 0.0028
702 SEROTONIN SYNDROME 53 0.0028
703 HYPOCALCAEMIA 52 0.0027
704 PAIN IN EXTREMITY 803 0.0027
705 BLOOD PRESSURE INCREASED 416 0.0027
706 ABDOMINAL DISTENSION 284 0.0027
707 EYE SWELLING 101 0.0027
708 UNRESPONSIVE TO STIMULI 70 0.0027
709 LABORATORY TEST ABNORMAL 80 0.0027
710 LIP SWELLING 90 0.0027
711 CONTUSION 260 0.0027
712 SPINAL FRACTURE 54 0.0027
713 ABDOMINAL DISCOMFORT 451 0.0027
714 BURNING SENSATION 188 0.0027
715 NEURALGIA 65 0.0027
716 DIVERTICULITIS 74 0.0027
717 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59 0.0027
718 APHASIA 80 0.0026
719 LOCALISED INFECTION 64 0.0026
720 HYPERHIDROSIS 339 0.0026
721 INTERSTITIAL LUNG DISEASE 127 0.0026
722 INCREASED APPETITE 50 0.0026
723 DYSGEUSIA 194 0.0026
724 BONE MARROW FAILURE 53 0.0026
725 RASH MACULAR 91 0.0026
726 BONE LOSS 39 0.0026
727 IMMUNE SYSTEM DISORDER 34 0.0026
728 MUSCULOSKELETAL STIFFNESS 226 0.0026
729 CYST 32 0.0026
730 DYSSTASIA 75 0.0026
731 FATIGUE 1999 0.0026
732 BASAL CELL CARCINOMA 40 0.0026
733 WEIGHT INCREASED 573 0.0026
734 LETHARGY 147 0.0026
735 EPISTAXIS 191 0.0026
736 ASCITES 75 0.0025
737 HALLUCINATION 192 0.0025
738 BLISTER 143 0.0025
739 DIABETES MELLITUS 194 0.0025
740 EATING DISORDER 54 0.0025
741 FLATULENCE 143 0.0025
742 TASTE DISORDER 51 0.0025
743 CHOKING 49 0.0025
744 HYPERTHYROIDISM 36 0.0025
745 PNEUMONIA ASPIRATION 62 0.0025
746 DERMATITIS 52 0.0025
747 TARDIVE DYSKINESIA 70 0.0025
748 JOINT STIFFNESS 65 0.0025
749 PRODUCT USE COMPLAINT 39 0.0025
750 DYSARTHRIA 93 0.0025
751 INSOMNIA 657 0.0025
752 DIALYSIS 35 0.0025
753 TYPE 2 DIABETES MELLITUS 83 0.0025
754 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 444 0.0025
755 PRURITUS 943 0.0025
756 BLOOD CHOLESTEROL INCREASED 114 0.0024
757 ABSCESS 39 0.0024
758 SKIN EXFOLIATION 206 0.0024
759 IMPAIRED HEALING 80 0.0024
760 BEDRIDDEN 32 0.0024
761 ABORTION SPONTANEOUS 97 0.0024
762 AKATHISIA 33 0.0024
763 SKIN REACTION 34 0.0024
764 PANCREATITIS 127 0.0024
765 NEUROTOXICITY 42 0.0024
766 PHOTOPHOBIA 45 0.0024
767 ARRHYTHMIA 113 0.0024
768 MUSCULOSKELETAL PAIN 125 0.0024
769 GAIT DISTURBANCE 455 0.0024
770 MANIA 39 0.0024
771 SENSORY DISTURBANCE 38 0.0024
772 MIGRAINE 226 0.0024
773 DRY EYE 118 0.0024
774 DIZZINESS 1177 0.0024
775 AGITATION 173 0.0024
776 SWELLING 220 0.0023
777 HERPES ZOSTER 135 0.0023
778 HYPOAESTHESIA ORAL 35 0.0023
779 ECZEMA 121 0.0023
780 IMPAIRED WORK ABILITY 49 0.0023
781 PRODUCT TASTE ABNORMAL 31 0.0023
782 AGGRESSION 114 0.0023
783 RASH PAPULAR 51 0.0023
784 EYE PAIN 128 0.0023
785 ABASIA 56 0.0023
786 FALL 754 0.0023
787 ILL-DEFINED DISORDER 137 0.0023
788 POLLAKIURIA 94 0.0023
789 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
790 DRY MOUTH 181 0.0022
791 POOR QUALITY SLEEP 48 0.0022
792 HERNIA 43 0.0022
793 COORDINATION ABNORMAL 31 0.0022
794 FEEDING DISORDER 45 0.0022
795 BLOOD URINE PRESENT 42 0.0022
796 BLOOD TRIGLYCERIDES INCREASED 39 0.0022
797 COMPLICATION ASSOCIATED WITH DEVICE 32 0.0022
798 FLUID OVERLOAD 32 0.0022
799 MELAENA 48 0.0022
800 MUSCLE SPASMS 399 0.0022
801 SKIN ULCER 56 0.0022
802 COGNITIVE DISORDER 101 0.0022
803 TOOTH DISORDER 48 0.0022
804 EYE IRRITATION 124 0.0022
805 PRODUCT AVAILABILITY ISSUE 49 0.0021
806 HEAD DISCOMFORT 38 0.0021
807 CRYING 78 0.0021
808 STOMATITIS 130 0.0021
809 MOBILITY DECREASED 154 0.0021
810 THYROID DISORDER 33 0.0021
811 LOSS OF CONSCIOUSNESS 274 0.0021
812 PERIPHERAL SWELLING 329 0.0021
813 RED BLOOD CELL COUNT DECREASED 61 0.0021
814 SURGERY 125 0.0021
815 RESTLESSNESS 78 0.0021
816 MUSCULAR WEAKNESS 241 0.0021
817 BALANCE DISORDER 183 0.0021
818 BONE PAIN 124 0.0021
819 DYSKINESIA 86 0.0021
820 PROTEINURIA 40 0.0021
821 EXTRAPYRAMIDAL DISORDER 52 0.0021
822 URINARY INCONTINENCE 62 0.0021
823 VISION BLURRED 287 0.0021
824 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
825 CONFUSIONAL STATE 337 0.0021
826 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 61 0.0021
827 LIVER DISORDER 92 0.0021
828 HAEMORRHAGE INTRACRANIAL 31 0.0021
829 LIMB DISCOMFORT 64 0.0021
830 RESPIRATORY ARREST 57 0.0021
831 HEPATIC FUNCTION ABNORMAL 77 0.0021
832 ACUTE MYELOID LEUKAEMIA 32 0.0021
833 THERAPEUTIC RESPONSE SHORTENED 68 0.0020
834 ACUTE MYOCARDIAL INFARCTION 60 0.0020
835 POST PROCEDURAL COMPLICATION 39 0.0020
836 NEUTROPENIA 276 0.0020
837 ARTHRALGIA 844 0.0020
838 DISABILITY 40 0.0020
839 OSTEONECROSIS OF JAW 50 0.0020
840 RASH GENERALISED 52 0.0020
841 OCULAR HYPERAEMIA 95 0.0020
842 HYPOGLYCAEMIA 97 0.0020
843 CIRCULATORY COLLAPSE 34 0.0020
844 NIGHTMARE 69 0.0020
845 INTESTINAL OBSTRUCTION 75 0.0020
846 PARAESTHESIA 313 0.0020
847 AMNESIA 129 0.0020
848 URINARY RETENTION 66 0.0020
849 GLAUCOMA 38 0.0020
850 HAEMATEMESIS 50 0.0020
851 DISORIENTATION 78 0.0020
852 GLOSSODYNIA 44 0.0020
853 DIPLOPIA 51 0.0020
854 DERMATITIS ATOPIC 103 0.0020
855 OSTEONECROSIS 64 0.0019
856 MUCOSAL INFLAMMATION 51 0.0019
857 MYALGIA 331 0.0019
858 TOXICITY TO VARIOUS AGENTS 328 0.0019
859 SYSTEMIC LUPUS ERYTHEMATOSUS 69 0.0019
860 ROAD TRAFFIC ACCIDENT 81 0.0019
861 CARDIAC DISORDER 181 0.0019
862 PELVIC PAIN 35 0.0019
863 PARANOIA 33 0.0019
864 INFLUENZA LIKE ILLNESS 157 0.0019
865 PERICARDITIS 32 0.0019
866 MENTAL IMPAIRMENT 46 0.0019
867 HYPOAESTHESIA 284 0.0019
868 GASTROINTESTINAL HAEMORRHAGE 158 0.0019
869 DEPRESSED LEVEL OF CONSCIOUSNESS 74 0.0019
870 FEELING ABNORMAL 448 0.0019
871 PSYCHOMOTOR HYPERACTIVITY 31 0.0019
872 HEAD INJURY 58 0.0018
873 PLATELET COUNT DECREASED 195 0.0018
874 ERUCTATION 35 0.0018
875 CONVULSION 103 0.0018
876 INCORRECT PRODUCT ADMINISTRATION DURATION 39 0.0018
877 ARTHROPATHY 100 0.0018
878 NERVOUSNESS 94 0.0018
879 FEELING COLD 50 0.0018
880 BLOOD PRESSURE DECREASED 119 0.0018
881 FLUID RETENTION 91 0.0018
882 UNEVALUABLE EVENT 135 0.0018
883 WHITE BLOOD CELL COUNT DECREASED 192 0.0018
884 LOWER LIMB FRACTURE 34 0.0018
885 PRODUCT USE ISSUE 332 0.0018
886 HOT FLUSH 133 0.0018
887 VISUAL IMPAIRMENT 218 0.0018
888 ADVERSE DRUG REACTION 158 0.0018
889 CARDIAC FAILURE 141 0.0018
890 HEPATIC CIRRHOSIS 33 0.0018
891 JOINT SWELLING 210 0.0017
892 PSORIATIC ARTHROPATHY 70 0.0017
893 FEELING HOT 105 0.0017
894 PRURITUS GENERALISED 37 0.0017
895 HYPERSOMNIA 49 0.0017
896 SPEECH DISORDER 89 0.0017
897 BLINDNESS 69 0.0017
898 SKIN DISORDER 56 0.0017
899 GAIT INABILITY 56 0.0017
900 MEDICATION ERROR 93 0.0017
901 DISTURBANCE IN ATTENTION 90 0.0017
902 MEMORY IMPAIRMENT 229 0.0017
903 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
904 ANGER 56 0.0017
905 MOVEMENT DISORDER 53 0.0016
906 PRODUCT ADMINISTRATION ERROR 33 0.0016
907 THERAPEUTIC RESPONSE DECREASED 98 0.0016
908 FEMUR FRACTURE 50 0.0016
909 CEREBRAL INFARCTION 39 0.0016
910 SKIN CANCER 34 0.0016
911 MOOD SWINGS 50 0.0016
912 ABNORMAL BEHAVIOUR 62 0.0016
913 CEREBRAL HAEMORRHAGE 56 0.0016
914 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
915 MUSCLE TWITCHING 36 0.0016
916 ERECTILE DYSFUNCTION 40 0.0016
917 EYE DISORDER 51 0.0015
918 GASTRIC DISORDER 52 0.0015
919 PRODUCT PRESCRIBING ERROR 36 0.0015
920 FLUSHING 153 0.0015
921 EXPOSURE VIA SKIN CONTACT 39 0.0015
922 CARDIOVASCULAR DISORDER 38 0.0015
923 CEREBROVASCULAR ACCIDENT 253 0.0015
924 COMA 71 0.0015
925 NERVOUS SYSTEM DISORDER 46 0.0015
926 SUICIDAL IDEATION 132 0.0014
927 DRUG EXPOSURE DURING PREGNANCY 49 0.0014
928 SOMNOLENCE 288 0.0014
929 INTENTIONAL PRODUCT USE ISSUE 125 0.0014
930 NEUTROPHIL COUNT DECREASED 58 0.0014
931 DEVICE DELIVERY SYSTEM ISSUE 38 0.0014
932 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
933 VISUAL ACUITY REDUCED 46 0.0014
934 ABNORMAL DREAMS 38 0.0014
935 EPILEPSY 42 0.0014
936 NEEDLE ISSUE 39 0.0013
937 SEIZURE 154 0.0013
938 PLASMA CELL MYELOMA 52 0.0013
939 MYELOSUPPRESSION 48 0.0013
940 SUICIDE ATTEMPT 79 0.0013
941 MOOD ALTERED 35 0.0013
942 MYOCARDIAL INFARCTION 215 0.0012
943 THERAPEUTIC RESPONSE UNEXPECTED 55 0.0012
944 PAIN OF SKIN 33 0.0012
945 RHEUMATOID ARTHRITIS 139 0.0012
946 IRRITABILITY 73 0.0012
947 DRY SKIN 159 0.0012
948 ALOPECIA 226 0.0011
949 ACCIDENTAL OVERDOSE 42 0.0011
950 VAGINAL HAEMORRHAGE 49 0.0011
951 THERAPEUTIC PRODUCT EFFECT DECREASED 50 0.0011
952 DEATH 959 0.0011
953 INTENTIONAL PRODUCT MISUSE 96 0.0011
954 EXTRA DOSE ADMINISTERED 44 0.0011
955 BLOOD GLUCOSE INCREASED 199 0.0011
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 214 0.0011
957 NEOPLASM MALIGNANT 68 0.0010
958 INCORRECT DOSE ADMINISTERED 232 0.0010
959 INJECTION SITE PRURITUS 67 0.0010
960 PSORIASIS 130 0.0010
961 INJECTION SITE SWELLING 74 0.0010
962 NO ADVERSE EVENT 174 0.0010
963 DEVICE ISSUE 85 0.0009
964 INJECTION SITE PAIN 289 0.0009
965 BLOOD GLUCOSE DECREASED 45 0.0009
966 ADVERSE EVENT 86 0.0009
967 NEOPLASM PROGRESSION 32 0.0009
968 INJECTION SITE REACTION 61 0.0009
969 PRODUCT QUALITY ISSUE 119 0.0009
970 INTENTIONAL OVERDOSE 56 0.0009
971 INJECTION SITE MASS 32 0.0009
972 INJECTION SITE BRUISING 68 0.0009
973 DEVICE LEAKAGE 36 0.0008
974 SKIN IRRITATION 37 0.0008
975 OVERDOSE 166 0.0008
976 DRUG DOSE OMISSION BY DEVICE 60 0.0008
977 WITHDRAWAL SYNDROME 31 0.0007
978 INJECTION SITE ERYTHEMA 90 0.0007
979 ACNE 55 0.0007
980 THERAPY CESSATION 36 0.0007
981 PRODUCT SUBSTITUTION ISSUE 38 0.0007
982 SKIN BURNING SENSATION 44 0.0006
983 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
984 UNDERDOSE 39 0.0005
985 PRODUCT STORAGE ERROR 45 0.0005
986 ACCIDENTAL EXPOSURE TO PRODUCT 52 0.0005
987 DRUG DEPENDENCE 76 0.0005
988 DRUG WITHDRAWAL SYNDROME 37 0.0004
989 INJECTION SITE HAEMORRHAGE 32 0.0004
990 DRUG ABUSE 33 0.0004
991 DRUG DOSE OMISSION 62 0.0004